TENX conference cites levosimendan biological effects in sicker patients
TradingView News reports a TENX conference highlighted new levosimendan biological effects, especially in sicker patients, despite missing the primary endpoint after enrolling too many healthier subjects. Future trials will target higher disease-burden patients.